Menta Capital’s Purple Biotech PPBT Stock Holding History

Menta Capital’s Portfolio PPBT Stock Details PPBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-6	Closed	-$13K	–	581
2019 Q1	$13K	Sell	6 -6	-50%	-$14.4K	0.01%	470
2018 Q4	$16K	Sell	12 -16	-57%	-$40.3K	0.01%	531
2018 Q3	$97K	Buy	+28	New	+$111K	0.03%	532
2017 Q4	–	Sell	-17	Closed	-$71K	–	772
2017 Q3	$71K	Sell	17 -19	-53%	-$70.8K	0.01%	730
2017 Q2	$111K	Sell	36 -2	-5%	-$7.29K	0.01%	737
2017 Q1	$145K	Sell	38 -3	-7%	-$14.3K	0.01%	766
2016 Q4	$257K	Buy	41 +10	+32%	+$69.6K	0.02%	780
2016 Q3	$214K	Buy	31 +23	+288%	+$143K	0.02%	726
2016 Q2	$50K	Buy	+8	New	+$80.1K	0.01%	833

Other funds holding PPBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $7.33B AUM 16.07% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Menta Capital's PPBT Position: Q2 2019 in Review

Menta Capital sold out of Purple Biotech (PPBT) in Q2 2019, closing a stake of 6 shares — an estimated $13K sold.

Menta Capital first reported a position in PPBT in Q2 2016 and held it in 9 quarters. The position peaked at $257K in Q4 2016. 5 funds tracked by Wall St. Rank hold PPBT as of Q2 2019.

Menta Capital reported no remaining Purple Biotech position as of Q2 2019 after selling out during the quarter.
Menta Capital sold 6 Purple Biotech shares in Q2 2019, an estimated $13K.
Menta Capital first reported a position in Purple Biotech in Q2 2016 and held it in 9 quarters.
Menta Capital's Purple Biotech position peaked at $257K in Q4 2016.
5 funds tracked by Wall St. Rank held Purple Biotech as of Q2 2019.

Based on Menta Capital's 13F filing for Q2 2019, filed 7 Aug 2019.